Benjamin F. Edwards & Company’s Core Laboratories CLB Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$2K	Buy	78 +35	+81%	+$619	﹤0.01%	2021
2024 Q1	$1K	Buy	+43	New	+$676	﹤0.01%	2069
2019 Q3	–	Sell	-19	Closed	-$1K	–	1840
2019 Q2	$1K	Buy	+19	New	+$1.11K	﹤0.01%	1837
2017 Q2	–	Sell	-100	Closed	-$12K	–	1453
2017 Q1	$12K	Hold	100	–	–	﹤0.01%	958
2016 Q4	$12K	Hold	100	–	–	﹤0.01%	892
2016 Q3	$11K	Hold	100	–	–	﹤0.01%	821
2016 Q2	$12K	Hold	100	–	–	﹤0.01%	754
2016 Q1	$11K	Hold	100	–	–	﹤0.01%	783
2015 Q4	$11K	Hold	100	–	–	﹤0.01%	814
2015 Q3	$10K	Hold	100	–	–	﹤0.01%	865
2015 Q2	$11K	Hold	100	–	–	﹤0.01%	904
2015 Q1	$10K	Buy	+100	New	+$10.7K	﹤0.01%	890

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Benjamin F. Edwards & Company's CLB Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Core Laboratories (CLB) stake by 81% in Q2 2024, buying an estimated $619 and bringing the position to 78 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Benjamin F. Edwards & Company first reported a position in CLB in Q1 2015 and has held it in 12 quarters since. The position peaked at $12K in Q1 2017. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

Benjamin F. Edwards & Company held 78 shares of Core Laboratories worth $2K as of Q2 2024.
Benjamin F. Edwards & Company bought 35 Core Laboratories shares in Q2 2024, an estimated $619.
Core Laboratories made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #2021 holding.
Benjamin F. Edwards & Company first reported a position in Core Laboratories in Q1 2015 and has held it in 12 quarters since.
Benjamin F. Edwards & Company's Core Laboratories position peaked at $12K in Q1 2017.
194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.